Manufacturing facility
Ningbo Shuangcheng Pharmaceutical Co., Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No. 866, Binhai Fourth Road, Hangzhou Bay New Zone, Cixi city, Ningbo, Zhejiang 315336, China (CHN)
- Operations here
- analysislabelmanufacturepacksterilize
- FDA identifiers
- FEI 3014148045 · DUNS 544337902
Drugs this plant is listed as making
4 distinct drugs across 8 products name this site in their FDA label.
- BortezomibNingbo Shuangcheng Pharmaceutical Co., Ltd.
- docetaxelZydus Pharmaceuticals USA Inc.
- PaclitaxelBluePoint Laboratories
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.